High-risk human papillomavirus test a good option for cervical cancer screening

被引:0
|
作者
Printz, Carrie
机构
关键词
D O I
10.1002/cncr.31883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4591 / 4591
页数:1
相关论文
共 50 条
  • [1] Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
    Stuebs, Frederik A.
    Koch, Martin C.
    Dietl, Anna K.
    Adler, Werner
    Geppert, Carol
    Hartmann, Arndt
    Knoell, Antje
    Beckmann, Matthias W.
    Mehlhorn, Grit
    Schulmeyer, Carla E.
    Gass, Paul
    [J]. DIAGNOSTICS, 2022, 12 (07)
  • [2] High-risk Human Papillomavirus Testing for Cervical Cancer Screening
    Totten, Stephanie P. S.
    Romero, Joan Miguel
    [J]. JAMA ONCOLOGY, 2021, 7 (07) : 1066 - 1067
  • [3] High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply
    Dang, Le
    Qiao, Youlin
    Lang, Jinghe
    [J]. JAMA ONCOLOGY, 2021, 7 (07) : 1067 - 1068
  • [4] Improving the effectiveness of cervical cancer screening: Managing positive high-risk human papillomavirus results
    Tay, Sun Kuie
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2024, 53 (06) : 342 - 351
  • [5] Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
    Daponte, Alexandros
    Pournaras, Spyros
    Tsakris, Athanassios
    [J]. WOMENS HEALTH, 2014, 10 (02) : 115 - 118
  • [6] Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States Is It Time?
    Flanagan, Melina B.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (06) : 688 - 692
  • [7] Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening?
    Kiff, Jaime M.
    Cotter, Madisen
    Munro, Elizabeth G.
    Leonard, Molly E.
    Morgan, Terry K.
    Bruegl, Amanda S.
    [J]. JOURNAL OF WOMENS HEALTH, 2021, 30 (07) : 972 - 978
  • [8] Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
    Gustavsson, Inger
    Aarnio, Riina
    Myrnas, Mattias
    Hedlund-Lindberg, Julia
    Taku, Ongeziwe
    Meiring, Tracy
    Wikstrom, Ingrid
    Enroth, Stefan
    Williamson, Anna-Lise
    Olovsson, Matts
    Gyllensten, Ulf
    [J]. VIROLOGY JOURNAL, 2019, 16 (01)
  • [9] Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
    Inger Gustavsson
    Riina Aarnio
    Mattias Myrnäs
    Julia Hedlund-Lindberg
    Ongeziwe Taku
    Tracy Meiring
    Ingrid Wikström
    Stefan Enroth
    Anna-Lise Williamson
    Matts Olovsson
    Ulf Gyllensten
    [J]. Virology Journal, 16
  • [10] High-risk human papillomavirus test in anal smears: can it optimize the screening for anal cancer?
    Kimura, Cintia M. S.
    Nahas, Caio S. R.
    Silva-Filho, Edesio, V
    Ribeiro, Vinicius L.
    Segurado, Aluisio C.
    Alcantara, Flavio F. P.
    Cecconello, Ivan
    Nahas, Sergio C.
    [J]. AIDS, 2021, 35 (05) : 737 - 745